Australian stocks traded sideways today with the ASX200 putting on just 2.4 points. Find out which immuno-oncology company has empirical research demonstrating promising inhibition of tumour cells by its peptide vaccine.
Liberty Resources will transition to a revenue generating tech company, after shareholders overwhelmingly voted for a change in the business’ main operations, its board and the company’s name.
Petrophysical testing from the historical Amamoor and Upper Kandanga manganese mines indicates mineralisation continues at depth. Ground based IP/ Resistivity surveys could define blind mineralisation along strike from and at depth below known mineralised zones. The Mary Valley project is located just 15 kilometres south of the town of Gympie.
The Abita well is cleaning up after recompletion work was completed and is now producing 1 million cubic feet of gas and 5 barrels of oil per day. There is potential for further improvements once stabilised rates have been achieved.
Isabel Nickel project is considered to be one of the largest nickel laterite deposits in the Pacific with the company targeting the establishment of a DSO operation by late 2015.
Axiom Mining has now raised A$4 million after attracting a number of institutional and high net worth investors.
Research has demonstrated promising inhibition of tumour cells by Her-Vaxx compared to Herceptin in tumour model. The Phase 1b/2 clinical trial to confirm safety, select optimal dose and assess clinical efficacy of the vaccine remains on track to begin in the second half of 2015.
The company is on target for strong first year of revenue working with more than 20 customers in pre-production, production and scale-up. Significantly higher revenue potential for Alexium’s Fire Retardant (FR) products is expected in 2016.
The discovery of substantial gold nuggets weighing 8 and 10 ounces upgrades the prospectivity of the Mt Remarkable gold project, a forgotten but still highly prospective greenstone belt located within hauling distance to Leonora. The company will carry out reconnaissance work in June, possibly some scout aircore drilling.
Drilling will be carried out over prioritised targets. This includes extending the mineralised strike extent at the Kabikupa prospect to 1,800 metres from 800 metres. Further intersections of up to 7 metres at 0.92% copper have also been received from three holes drilled previously at the prospect.
Queensland Bauxite has committing to a significant drilling program at its flagship South Johnstone. The project has an overall massive exploration target area of between 193 million tonnes and 405 million tonnes. Current drilling to date is still only a small sub-set of that area.
The market potential in identifying kidney disease is significant and growing. In Australia, diabetes in the fastest growing chronic disease with a total of 1.1 million with either Type 1 or Type 2 diabetes, and around 100,000 new cases reported each year.
Lepidico Limited has produced lithium carbonate from mica using the L-Max process at its mini-plant in Perth. This will provide data to support the commercialisation of the process.